Editorial: γδ T Cells in Cancer

Editorial: γδ T Cells in Cancer

Bibliographic Details
Main Authors:	Seth B. Coffelt, Dieter Kabelitz, Bruno Silva-Santos, Jurgen Kuball, Willi Born, Ilan Bank
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Immunology
Subjects:	γδ T cells cancer butyrophilin immunotherapy bisphoshonates
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.602411/full

Similar Items

A multispectral immunohistochemistry panel to investigate γδ T cells and butyrophilin molecules in the tumour microenvironment
by: Jessica Da Gama Duarte, et al.
Published: (2022-06-01)

Harnessing γδ T Cells against Human Gynecologic Cancers
by: Jose R. Conejo-Garcia, et al.
Published: (2024-02-01)

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
by: Juan-Luis Blazquez, et al.
Published: (2018-07-01)

Editorial: Next generation γδ T cell-based tumor immunotherapy
by: Andy Hee-Meng Tan, et al.
Published: (2022-09-01)

Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer
by: Rinkee Kumari, et al.
Published: (2023-05-01)

Cancer immunotherapy using γδT cells: dealing with diversity
by: Wouter eScheper, et al.
Published: (2014-11-01)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
by: Emilien Billon, et al.
Published: (2021-04-01)

An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
by: Thomas Herrmann, et al.
Published: (2020-06-01)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
by: Derek Lee, et al.
Published: (2022-06-01)

Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More
by: Thomas Herrmann, et al.
Published: (2022-03-01)

The Role of γδ T Cells in Fibrotic Diseases
by: Ilan Bank
Published: (2016-10-01)

Bibliometrics Analysis of Butyrophilins as Immune Regulators [1992–2019] and Implications for Cancer Prognosis
by: Yixi Wang, et al.
Published: (2020-06-01)

The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma
by: Susann Schönefeldt, et al.
Published: (2021-12-01)

High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis
by: Huanzi Lu, et al.
Published: (2020-09-01)

Expanded human blood-derived γδT cells display potent antigen-presentation functions
by: Mohd Wajid Ali Khan, et al.
Published: (2014-07-01)

The capability of heterogeneous γδ T cells in cancer treatment
by: Wenyi Yan, et al.
Published: (2023-11-01)

Anti-cancer γδ T lymphocytes: contradictory past and promising future
by: Alessandro Poggi, et al.
Published: (2022-04-01)

The emerging role of γδ T cells in cancer immunotherapy
by: Oliver Nussbaumer, et al.
Published: (2019-07-01)

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
by: Trudy Straetemans, et al.
Published: (2018-05-01)

γδ T cells in immunotherapies for B-cell malignancies
by: Léa Rimailho, et al.
Published: (2023-06-01)

γδT cells: alternative treasure in antitumor immunity
by: Xiangjin Zhang, et al.
Published: (2022-02-01)

γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids
by: Junxue Dong, et al.
Published: (2023-11-01)

Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
by: Cella Luigi, et al.
Published: (2011-08-01)

Biological characteristics of γδT cells and application in tumor immunotherapy
by: Renhong Zhu, et al.
Published: (2023-01-01)

γδ T cells: a sparkling star for clinical immunotherapy
by: Jiamian Zheng, et al.
Published: (2022-08-01)

Comparing Mouse and Human Tissue-Resident γδ T Cells
by: Guanyu Qu, et al.
Published: (2022-06-01)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
by: Yuan Song, et al.
Published: (2022-06-01)

Intracellular radar: Understanding γδ T cell immune surveillance and implications for clinical strategies in oncology
by: Anne B. C. Cherry, et al.
Published: (2022-09-01)

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
by: Yuxia Liu, et al.
Published: (2020-05-01)

γδ T cells as a potential therapeutic agent for glioblastoma
by: In Kang, et al.
Published: (2023-10-01)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
by: Elena Lo Presti, et al.
Published: (2017-10-01)

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells
by: Lola Boutin, et al.
Published: (2018-04-01)

Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
by: Megan Yuan, et al.
Published: (2024-03-01)

Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate
by: Helena Migalovich Sheikhet, et al.
Published: (2018-04-01)

Tumor-associated protein ligands recognized by human γδ T cell receptor and their implications in cancer therapy
by: Chang Liu, et al.
Published: (2022-02-01)

The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells
by: Rushikesh Sudam Patil, et al.
Published: (2015-02-01)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
by: Mahboubeh Yazdanifar, et al.
Published: (2020-05-01)

Immune Effects of γδ T Cells in Colorectal Cancer: A Review
by: Rulan Ma, et al.
Published: (2020-09-01)

Gamma-delta (γδ) T cells: friend or foe in cancer development?
by: Yijing Zhao, et al.
Published: (2018-01-01)

Role of γδ T cells in mucosal intranet
by: Masafumi Yamamoto, et al.
Published: (1999-01-01)